AS Ferncliff has been merged with Ferncliff TIH AS. Both companies are indirectly 100% owned by board member Øystein Stray Spetalen. 

As a result of the completion of the merger, 99 225 shares owned by AS Ferncliff in Vistin Pharma ASA, corresponding to 0.22 % ownership, has been transferred from AS Ferncliff to Ferncliff TIH AS. 

After the transaction, the number of shares controlled by Øystein Stray Spetalen and associated companies remains unchanged at 8 596 285 shares, corresponding to 19.4%